OpGen subsidiary Ares Genetics demonstrated feasibility and next generation sequencing based antibiotic susceptibility testing in multi-center study
| | | | |

OpGen subsidiary Ares Genetics demonstrated feasibility and next generation sequencing based antibiotic susceptibility testing in multi-center study

On Apr. 16, 2020, OpGen announced that a study on the feasibility and potential of antibiotic susceptibility testing…

Dr. Claudia Kleinman, Dr. Nada Jabado, and Dr. Michael Taylor discovered that pediatric brain tumors derive from a genetic event early in cellular development
| | | |

Dr. Claudia Kleinman, Dr. Nada Jabado, and Dr. Michael Taylor discovered that pediatric brain tumors derive from a genetic event early in cellular development

On Nov. 25, 2019, Dr. Claudia Kleinman, Dr. Nada Jabado, and Dr. Michael Taylor discovered that pediatric brain…